Physician profile
Caroline N Jackson
NPI 1619311396
$8,766.58
in general payments reported to CMS, 2019-2025
42 companies · $3,054 in 2025
The $3,054 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $266 · 2021: $681 · 2022: $930 · 2023: $1,375 · 2024: $2,260 · 2025: $3,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,158 · Travel and Lodging: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,158.27 |
| Travel and Lodging | $530.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,078.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Convatec INC. | $1,048.19 | 2025 | |
| Abbvie INC. | $976.79 | 2021-2025 | |
| Pfizer INC. | $757.06 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $690.71 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $604.28 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $414.07 | 2020-2025 | Xifaxan |
| Abbott Laboratories | $394.22 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $342.57 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $337.72 | 2023-2025 | |
| Exact Sciences Corporation | $326.11 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $230.20 | 2020-2025 | Evenity, Repatha, Otezla |
| Astellas Pharma US INC | $170.00 | 2024-2025 | Veozah |
| Dexcom, INC. | $119.89 | 2022-2025 | Dexcom G6 Transmitter |
| Currax Pharmaceuticals LLC | $111.83 | 2024-2025 | Contrave |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.